Senior Physician and researcherHadassah medical center, Israel
OA-34: Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis
Friday, September 29, 20235:18 PM – 5:30 PM EEST